Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (JPRN-UMIN000058671) titled 'whole brain radiotherapy for metastatic brain tumors, scalp sparing radiotherapy using IMRT: multi-insitutional study' on Aug. 1.

Study Type: Interventional

Study Design: Single arm Non-randomized

Primary Sponsor: Juntendo University

Condition: metastatic brain tumor

Intervention: Employing IMRT, reduce the dose to the scalp during whole brain radiotherapy

Recruitment Status: Recruiting

Phase: Phase II

Date of First Enrollment: 2023/03/24

Target Sample Size: 40

Countries of Recruitment: Japan

To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000067091

Publ...